These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 668810)

  • 1. Some effects of disopyramide and its N-dealkylated metabolite on isolated nerve and cardiac muscle.
    Grant AM; Marshall RJ; Ankier SI
    Eur J Pharmacol; 1978 Jun; 49(4):389-94. PubMed ID: 668810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological effects of disopyramide and quinidine on guinea pig atria and canine cardiac purkinje fibers. Dependence on underlying cholinergic tone.
    Mirro MJ; Watanabe AM; Bailey JC
    Circ Res; 1980 May; 46(5):660-8. PubMed ID: 7363415
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of 4 antiarrhythmic drugs on sinoatrial conduction time in isolated and blood-perfused dog atria.
    Shimotori M; Kobayashi M; Chiba S
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):67-79. PubMed ID: 6721625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disopyramide phosphate: is it just another quinidine.
    Kus T; Sasyniuk BI
    Can J Physiol Pharmacol; 1978 Apr; 56(2):326-31. PubMed ID: 638888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of quinidine, procainamide and disopyramide on automaticity and cyclic AMP content of guinea-pig atria.
    Mirro MJ
    J Mol Cell Cardiol; 1981 Jul; 13(7):641-53. PubMed ID: 6268798
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of etafenone and antiarrhythmic drugs on Na and Ca channels of guinea pig atrial muscle.
    Hashimoto K; Satoh H; Imai S
    J Cardiovasc Pharmacol; 1979; 1(5):561-70. PubMed ID: 94412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of disopyramide on SA nodal pacemaker activity and contractility in the isolated blood-perfused atrium of the dog.
    Chiba S; Kobayashi M; Furukawa Y
    Eur J Pharmacol; 1979 Jul; 57(1):13-9. PubMed ID: 477737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of disopyramide, compared with procainamide and quinidine, on isolated dog arteries in response to transmural stimulation and norepinephrine.
    Toda N; Konishi M; Okunishi H; Miyazaki M
    J Cardiovasc Pharmacol; 1981; 3(6):1332-41. PubMed ID: 6173534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local anesthetic activity and disopyramide toxicity.
    Malavé A; Holsapple MP; Yim GK
    Arch Int Pharmacodyn Ther; 1983 Jun; 263(2):254-63. PubMed ID: 6603827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac effects of disopyramide.
    Danilo P; Rosen MR
    Am Heart J; 1976 Oct; 92(4):532-6. PubMed ID: 785992
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticholinergic effects of disopyramide and quinidine on guinea pig myocardium. Mediation by direct muscarinic receptor blockade.
    Mirro MJ; Manalan AS; Bailey JC; Watanabe AM
    Circ Res; 1980 Dec; 47(6):855-65. PubMed ID: 7192183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological effects of a new antiarrhythmic agent, lorcainide, on the isolated cardiac muscle fiber as compared with disopyramide.
    Shigenobu K; Atoda H; Asano T; Kasuya Y
    J Pharmacobiodyn; 1980 Dec; 3(12):677-85. PubMed ID: 7277183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of the atrium-specific positive inotropic activities of quinidine- and atropine-like agents in rats.
    Deng XF; Mulay S; Chemtob S; Varma DR
    J Pharmacol Exp Ther; 1997 Apr; 281(1):322-9. PubMed ID: 9103513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Disopyramide phosphate: electrophysiological and inotropic effects in isolated cat papillary muscles and comparison with quinidine (author's transl)].
    Scholz H
    Arzneimittelforschung; 1976 Apr; 26(4):469-73. PubMed ID: 988999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of disopyramide on left ventricular performance: the relationship of free and total concentrations of the drug and of its mono-N-dealkylated metabolite to noninvasive indices of function.
    Holt GW; Norris RL; Ravenscroft PJ; Bett JH; Dryburgh LG; Boyle CM
    J Cardiovasc Pharmacol; 1983; 5(1):51-4. PubMed ID: 6186859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative antidysrhythmic profiles of bepridil, amiodarone and disopyramide in the guinea-pig and dog.
    Labrid C; Leinot M; Beaughard M; Basiez M; Duchene-Marullaz P
    Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):87-97. PubMed ID: 6971633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of disopyramide and its mono-N-dealkylated metabolite in conscious dogs with chronic atrioventricular block: plasma concentration-response relationships.
    Dubray C; Boucher M; Paire M; Pinatel H; Duchêne-Marullaz P
    J Cardiovasc Pharmacol; 1986; 8(6):1229-34. PubMed ID: 2434751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse hemodynamic effects of intravenous disopyramide compared with quinidine in conscious dogs.
    Walsh RA; Horwitz LD
    Circulation; 1979 Nov; 60(5):1053-8. PubMed ID: 487539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational basis of antiarrhythmic therapy: clinical pharmacology of commonly used antiarrhythmic drugs.
    Singh BN
    Angiology; 1978 Mar; 29(3):206-42. PubMed ID: 347988
    [No Abstract]   [Full Text] [Related]  

  • 20. Observations on the effects of selected antiarrhythmic drugs on mammalian cardiac purkinje fibers with two levels of steady-state potential: influences of lidocaine, phenytoin, propranolol, disopyramide and procainamide on repolarization, action potential shape and conduction.
    Arnsdorf MF; Mehlman DJ
    J Pharmacol Exp Ther; 1978 Dec; 207(3):983-91. PubMed ID: 731444
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.